Drug regulators and trial designs should assess benefits that actually matter to people with cancer, says Ajay Aggarwal.

Original Source

As per Biomedical Waste (Management and Handling) Rules, 1998, every health care facility generating BMW needs to set up requisite BMW treatment systems on site or ensure requisite treatment of waste at common treatment facility. An attempt has been made to critically assess the current biomedical waste management practices followed by some Armed Force Hospitals.